Adicet Bio Inc has a consensus price target of $16.82, established from looking at the 29 latest analyst ratings. The last 3 analyst ratings were released from Wedbush, HC Wainwright & Co., and HC Wainwright & Co. on April 23, 2024, April 2, 2024, and March 20, 2024. With an average price target of $8.33 between Wedbush, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 338.60% upside for Adicet Bio Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
04/23/2024 | ACET | Buy Now | Adicet Bio | $1.90 | 163.16% | Wedbush | Robert Driscoll | → $5 | Reiterates | Outperform → Outperform | Get Alert |
04/02/2024 | ACET | Buy Now | Adicet Bio | $1.90 | 426.32% | HC Wainwright & Co. | Edward White | $10 → $10 | Maintains | Buy | Get Alert |
03/20/2024 | ACET | Buy Now | Adicet Bio | $1.90 | 426.32% | HC Wainwright & Co. | Edward White | → $10 | Reiterates | Buy → Buy | Get Alert |
03/20/2024 | ACET | Buy Now | Adicet Bio | $1.90 | 163.16% | Wedbush | Robert Driscoll | → $5 | Reiterates | Outperform → Outperform | Get Alert |
03/20/2024 | ACET | Buy Now | Adicet Bio | $1.90 | 900% | Canaccord Genuity | John Newman | → $19 | Reiterates | Buy → Buy | Get Alert |
02/02/2024 | ACET | Buy Now | Adicet Bio | $1.90 | 426.32% | HC Wainwright & Co. | Edward White | $26 → $10 | Maintains | Buy | Get Alert |
11/09/2023 | ACET | Buy Now | Adicet Bio | $1.90 | 163.16% | Wedbush | Robert Driscoll | $17 → $5 | Maintains | Outperform | Get Alert |
09/06/2023 | ACET | Buy Now | Adicet Bio | $1.90 | 1321.05% | Truist Securities | Asthika Goonewardene | → $27 | Reiterates | Buy → Buy | Get Alert |
08/11/2023 | ACET | Buy Now | Adicet Bio | $1.90 | 1268.42% | HC Wainwright & Co. | Edward White | $38 → $26 | Maintains | Buy | Get Alert |
08/10/2023 | ACET | Buy Now | Adicet Bio | $1.90 | 426.32% | BTIG | Justin Zelin | $20 → $10 | Maintains | Buy | Get Alert |
08/10/2023 | ACET | Buy Now | Adicet Bio | $1.90 | 794.74% | Wedbush | Robert Driscoll | → $17 | Reiterates | Outperform → Outperform | Get Alert |
06/27/2023 | ACET | Buy Now | Adicet Bio | $1.90 | 952.63% | Guggenheim | Michael Schmidt | → $20 | Downgrade | Buy → Neutral | Get Alert |
06/27/2023 | ACET | Buy Now | Adicet Bio | $1.90 | 1900% | HC Wainwright & Co. | Edward White | → $38 | Reiterates | Buy → Buy | Get Alert |
06/27/2023 | ACET | Buy Now | Adicet Bio | $1.90 | — | JMP Securities | Reni Benjamin | — | Downgrade | Market Outperform → Market Perform | Get Alert |
06/01/2023 | ACET | Buy Now | Adicet Bio | $1.90 | 215.79% | JP Morgan | Brian Cheng | $20 → $6 | Downgrade | Overweight → Neutral | Get Alert |
05/15/2023 | ACET | Buy Now | Adicet Bio | $1.90 | 900% | JMP Securities | Reni Benjamin | → $19 | Reiterates | Market Outperform → Market Outperform | Get Alert |
05/10/2023 | ACET | Buy Now | Adicet Bio | $1.90 | 1478.95% | Wedbush | Robert Driscoll | → $30 | Reiterates | → Outperform | Get Alert |
05/10/2023 | ACET | Buy Now | Adicet Bio | $1.90 | 1900% | HC Wainwright & Co. | Edward White | → $38 | Maintains | Buy | Get Alert |
03/16/2023 | ACET | Buy Now | Adicet Bio | $1.90 | 1478.95% | Wedbush | Robert Driscoll | → $30 | Reiterates | → Outperform | Get Alert |
The latest price target for Adicet Bio (NASDAQ: ACET) was reported by Wedbush on April 23, 2024. The analyst firm set a price target for $5.00 expecting ACET to rise to within 12 months (a possible 163.16% upside). 18 analyst firms have reported ratings in the last year.
The latest analyst rating for Adicet Bio (NASDAQ: ACET) was provided by Wedbush, and Adicet Bio reiterated their outperform rating.
There is no last upgrade for Adicet Bio.
The last downgrade for Adicet Bio Inc happened on June 27, 2023 when Guggenheim changed their price target from N/A to $20 for Adicet Bio Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Adicet Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Adicet Bio was filed on April 23, 2024 so you should expect the next rating to be made available sometime around April 23, 2025.
While ratings are subjective and will change, the latest Adicet Bio (ACET) rating was a reiterated with a price target of $0.00 to $5.00. The current price Adicet Bio (ACET) is trading at is $1.90, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.